Cover

Loading…
ArticleNumber e000782
Author Cagnazzo, Celeste
Pinto, Carmine
Author_xml – sequence: 1
  givenname: Carmine
  orcidid: 0000-0002-3159-5268
  surname: Pinto
  fullname: Pinto, Carmine
  email: pinto.carmine@ausl.re.it
  organization: Medical Oncology Unit, AUSL-IRCCS of Reggio Emilia, Reggio Emilia, Italy
– sequence: 2
  givenname: Celeste
  surname: Cagnazzo
  fullname: Cagnazzo, Celeste
  organization: Research and Clinical Development Unit, Pediatric Oncology and Hematology Unit, University of Turin, Turin, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32354722$$D View this record in MEDLINE/PubMed
BookMark eNqNkktv1DAUhS1UREvbf4CQl2xCbefhBCGkaniNVKmbtlvLsW8yLok92M6g2fHT8TATVLppV36d892re_waHVlnAaE3lLynNK8uIIzOrcFmjDCSEUJ4zV6gE0bKJuOENUcP9sfoPIT7pKG8SJfVK3Scs7wsOGMn6PfSaqNkNM4G7KGXXhvb47gCPEorexjBRuw6bGwEv0mHpJQDVoOxyTfg6I0cAv5l4gprP_UB68nPCDV5v_Mvru-WnzPa4ITzPVi1TTy8jHLYnqGXXQLA-WE9Rbdfv9wsvmdX19-Wi8urrC3qKmasrqRqpaZdwTooakpaSqsCFOekoV0pm4rVpWKEgi61zGWXZDVva0VLVbYyP0Wf9tz11I6gVWrLy0GsvRml3wonjfj_xZqV6N1GcEYp4UUCvDsAvPs5QYhiNEHBMEgLbgqC5Q2vyobmJEnfPqz1r8g89iT4sBco70Lw0All4t8QUmkzCErELmYxxyx2MYt9zMlcPDLP_CdshwFAmvLGgBdBmRQFaONBRaGdeQrw8RFg_gQ_YPsc-8Xe3o73z-v4D-IW6jQ
CitedBy_id crossref_primary_10_2169_internalmedicine_0492_22
crossref_primary_10_1016_j_mayocp_2023_02_003
crossref_primary_10_3390_biology9080181
crossref_primary_10_1177_0300891620977916
crossref_primary_10_1136_neurintsurg_2020_016502
crossref_primary_10_1016_j_ejca_2021_01_040
crossref_primary_10_1007_s10147_020_01806_7
ContentType Journal Article
Copyright Author (s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology.
2020 © 2020 THE AUTHORS. Published by Elsevier Limited on behalf of European Society for Medical Oncology.
2020 © 2020 THE AUTHORS. Published by Elsevier Limited on behalf of European Society for Medical Oncology. 2020
Copyright_xml – notice: Author (s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology.
– notice: 2020 © 2020 THE AUTHORS. Published by Elsevier Limited on behalf of European Society for Medical Oncology.
– notice: 2020 © 2020 THE AUTHORS. Published by Elsevier Limited on behalf of European Society for Medical Oncology. 2020
DBID 9YT
ACMMV
6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1136/esmoopen-2020-000782
DatabaseName BMJ Open Access Journals
BMJ Journals:Open Access
ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: ACMMV
  name: BMJ Journals:Open Access
  url: https://journals.bmj.com/
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2059-7029
EndPage e000782
ExternalDocumentID PMC7211074
32354722
10_1136_esmoopen_2020_000782
S2059702920300788
esmoopen
Genre Editorial
Commentary
GeographicLocations Italy
GeographicLocations_xml – name: Italy
GroupedDBID .1-
.FO
0R~
53G
5VS
9YT
AAEDW
AAXUO
ACGFS
ACMMV
ADBBV
ADVLN
AFJKZ
AFRHN
AITUG
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
BCNDV
EBS
FDB
GROUPED_DOAJ
HYE
KQ8
M48
M~E
O9-
OK1
RHI
ROL
RPM
Z5R
AALRI
AAYWO
ACVFH
ADCNI
ADRAZ
AEUPX
AFPUW
AIGII
AKBMS
AKYEP
APXCP
6I.
AAFTH
AFCTW
AAYXX
CITATION
AAHOK
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-b486t-286acbad1f42fe4810b1164ec77091f5a96285c201ed5da3af2fe87b8c15c5ba3
IEDL.DBID 9YT
ISSN 2059-7029
IngestDate Thu Aug 21 18:31:50 EDT 2025
Fri Jul 11 11:39:45 EDT 2025
Wed Feb 19 02:29:18 EST 2025
Tue Jul 01 01:19:27 EDT 2025
Thu Apr 24 23:05:34 EDT 2025
Tue Jul 25 20:57:14 EDT 2023
Tue Aug 26 16:54:54 EDT 2025
Thu Apr 24 22:52:06 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords COVID-19, SARS-CoV2, oncology, clinical trials
Language English
License This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, any changes made are indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
This is an open access article under the CC BY-NC license.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b486t-286acbad1f42fe4810b1164ec77091f5a96285c201ed5da3af2fe87b8c15c5ba3
Notes SourceType-Scholarly Journals-1
content type line 23
ObjectType-Editorial-2
ObjectType-Commentary-1
ORCID 0000-0002-3159-5268
OpenAccessLink http://dx.doi.org/10.1136/esmoopen-2020-000782
PMID 32354722
PQID 2397659130
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7211074
proquest_miscellaneous_2397659130
pubmed_primary_32354722
crossref_citationtrail_10_1136_esmoopen_2020_000782
crossref_primary_10_1136_esmoopen_2020_000782
elsevier_sciencedirect_doi_10_1136_esmoopen_2020_000782
elsevier_clinicalkey_doi_10_1136_esmoopen_2020_000782
bmj_primary_10_1136_esmoopen_2020_000782
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20200101
PublicationDateYYYYMMDD 2020-01-01
PublicationDate_xml – month: 1
  year: 2020
  text: 20200101
  day: 1
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle ESMO open
PublicationTitleAlternate ESMO Open
PublicationYear 2020
Publisher Elsevier Ltd
THE AUTHORS. Published by Elsevier Limited on behalf of European Society for Medical Oncology; Originally published by BMJ
Publisher_xml – name: Elsevier Ltd
– name: THE AUTHORS. Published by Elsevier Limited on behalf of European Society for Medical Oncology; Originally published by BMJ
References Ministry of health, recommendations for the management of oncological and onco-hematological patients in the course of a COVID-19. Emergency.
EMA. Guidance of the management of clinical trials during the COVID-19 (coronavirus) pandemic. version 2 (27/03/2020).
AIFA. Management of clinical studies in Italy in the course of a COVID-19 (coronavirus disease) emergency. version 1, 12/03/2020.
AIFA. Management of clinical studies in Italy in the course of a COVID-19 (coronavirus disease) emergency. version 2, 07/04/2020.
EMA. Guidance of the management of clinical trials during the COVID-19 (coronavirus) pandemic. version 1 (20/03/2020).
10.1136/esmoopen-2020-000782_bb0010
10.1136/esmoopen-2020-000782_bb0020
10.1136/esmoopen-2020-000782_bb0030
10.1136/esmoopen-2020-000782_bb0015
10.1136/esmoopen-2020-000782_bb0025
References_xml – article-title: Ministry of health, recommendations for the management of oncological and onco-hematological patients in the course of a COVID-19
  publication-title: Emergency
– reference: AIFA. Management of clinical studies in Italy in the course of a COVID-19 (coronavirus disease) emergency. version 1, 12/03/2020.
– reference: EMA. Guidance of the management of clinical trials during the COVID-19 (coronavirus) pandemic. version 1 (20/03/2020).
– reference: Ministry of health, recommendations for the management of oncological and onco-hematological patients in the course of a COVID-19. Emergency.
– reference: AIFA. Management of clinical studies in Italy in the course of a COVID-19 (coronavirus disease) emergency. version 2, 07/04/2020.
– reference: EMA. Guidance of the management of clinical trials during the COVID-19 (coronavirus) pandemic. version 2 (27/03/2020).
– ident: 10.1136/esmoopen-2020-000782_bb0030
– ident: 10.1136/esmoopen-2020-000782_bb0010
– ident: 10.1136/esmoopen-2020-000782_bb0020
– ident: 10.1136/esmoopen-2020-000782_bb0015
– ident: 10.1136/esmoopen-2020-000782_bb0025
SSID ssj0001742056
Score 2.1429663
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
bmj
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e000782
SubjectTerms Betacoronavirus
Clinical Laboratory Techniques
Clinical Trials as Topic - standards
Coronavirus Infections - diagnosis
Coronavirus Infections - epidemiology
COVID-19
COVID-19 Testing
COVID-19, SARS-CoV2, oncology, clinical trials
Humans
Italy
Pandemics
Patient Selection
Pneumonia, Viral - diagnosis
Pneumonia, Viral - epidemiology
Practice Guidelines as Topic
SARS-CoV-2
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkRAXxJvlJSNx4GJI_IjjA0KoUHWRFi4s6s2yHWcp6mZhsyvRGz-dcWxHLVC14pSDPXbiGWe-GXtmEHouqOWtaTypW2XBQGkNsYAaCKOFU9JIW7AQKDz7WB3M-YdDcbiDcs3WtID9P027UE9qvj5--fPHyRvY8K9TRZJXvl-uQhtwnA5h0qD1rqCroJtkKOYwS4B_8LqAJVgMJV3hoYgsqErxdOcNBDrHLr-dp7X-RqV_Xq48pa32b6IbCWbit1EubqEd391G12bpIP0O-jXtmuytw2u_CHLSLTCgQbwcL8TgVYuPTt2JhAFzICUeqn30OLhxcbPeLnocAx6HIVxM-oT3Pn2ZviOlwj4HecJ4eApLfXIXzffff947IKkYA7G8rjaE1pVx1jRly2nreV0WtgRTyzspAXK0wqgQjOkAT_hGNIaZFrrV0tauFE5Yw-6h3W7V-QcI81ZJz2zFitpySb0KDpi6gT6mqhx3E_QCllx_j-k29GCmsEpn7ujAHR25M0Es80W7lNQ81NY4voCKjFSXm0Vkluu8zvCL1SCEF9DJkS4BmghULkH5LEuWhv0eDnFM51fbXtMAIIUC6DFB96Okjd_AKBMh-SfMe0YGxw4hl_jZlu7o65BTPDoC-MP_fuNH6HrcNcE79RjtbtZb_wTw2sY-Hbbgb6oQP9g
  priority: 102
  providerName: Scholars Portal
Title Indications regarding the management of interventional clinical trials with drugs during the current COVID-19 emergency in Italy
URI https://esmoopen.bmj.com/content/5/2/e000782.full
https://www.clinicalkey.com/#!/content/1-s2.0-S2059702920300788
https://dx.doi.org/10.1136/esmoopen-2020-000782
https://www.ncbi.nlm.nih.gov/pubmed/32354722
https://www.proquest.com/docview/2397659130
https://pubmed.ncbi.nlm.nih.gov/PMC7211074
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV07b9wwDCbaBAiyFE36urQ9qECHLkbPlmTLY3BtkAvgdkmCdBIkWbom6PmKewzZ-tNLWZbzQpBbvFiUYJIyP1IiCfCZZ5o5VdtEuFKjg-JUohE1JDQbmbJQhR5Rnyhc_ciPz9jJBb-4cRTvneCnNP9ql7O57ySF8szaJGi0ac9h25dl8c5W-ev0JqaCfh4a9C5D7jHiXdihGeW-SiIaFD27eswkPYSc929O3jJFRy_hRYchyWEQ-h48s80-7FTdKfkr-Ddp6hiKIws79UrQTAlCPTLrb7uQuSOXty484oQxS5K0rTyWxMdoSb1YT5ckZDO2U5hQ0YmMf55PviVpSWzM4MT5yATB_PVrODv6fjo-TrpOC4lmIl8lmciV0apOHcucZSId6RT9KGuKAvGE46r0mZYGwYKtea2ocjhMFFqYlBuuFX0DW828se-AMFcWluqcjoRGFtvSR1dEjWNUnhtmBvAFWS7_hloasvVBaC6joKQXlAyCGgCNcpGmq1juG2f8eYIq6ak2W4VHkcvIZ_x_StTDJ-iKnq5DKwGFbED5KWqWxM3sT2hUY-frpcw8OuQl4ooBvA2a1n9D1Flc944O9gN8ofC7b5rL323B8ODls4PNWf8edsOO8bGmD7C1WqztR0RfKz1st9wQtg_HVXU-bGMY-KyY-A_1ui9W
linkProvider BMJ Publishing Group Ltd
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9wwEB5RkCiXCvpiS0tdqYdewm7iOE6OFRTtUpZeloqeLNuxtyA2i_Zx6K0_nXEcB2iF2HM8Y8Uzznwz8TcG-MwSlVpZmii3hcIExcpIIWqIaNLTBZdc9agjCg_Psv55enLBLtYgDlwYM59M3b1RB2py5SkNrklTteiybtI1PqIduMr0M9jgnDJ3iqv4Nborq2CqhzG9IcnFNGs1oj8kNYkaNWzBJk0oc40SMabgVI9Fpf9R57-HJ-9Fo-NteNHASPLV230H1kz1EjaHzY_yV_B3UJWhGkdmZuz8oBoTRHtk0h54IVNLLu-deUSFgShJ6ts85sSVaUk5W47nxBMaaxXaN3Uihz9-Do6iuCAmkDhRHxkgnv_zGs6Pv40O-1Fz2UKk0jxbREmeSa1kGds0sSbN456KMZUymnOEFJbJwpEtNeIFU7JSUmlxWM5VrmOmmZL0DaxX08rsAkltwQ1VGe3lCpfYFK7Akpc4RmaZTnUHvuCSixvfTkPUaQjNRDCUcIYS3lAdoMEuQjdNy93dGddPSEWt1GqzsGByEdYZP6ECo8oTcryVawCLByIrSH4KniVwP7ufNLIy0-VcJA4gsgKhRQfeek9r3yH4LM77wAfbAa5X-MMn1eXvume4T_TTd6sv_Ud43h8NT8Xp4Oz7Hmz53eNKT-9hfTFbmg8IxhZqv95-tz99Mf0
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9wwEB5RkFZcqtIX2wJ1pR56ye4mjuPkiIAVSwvtASp6smzH3lJ1s2gfh9760zuO4_ASYs_xjBXPOPPNxN8Y4BNLVGplaaLcFgoTFCsjhaghoslAF1xyNaCOKHx6lh1fpCeX7HINWODCmPlk6u6N6qnJb09pcE2aqkWf9ZO-8RGt5yrTvevSPoMNzjHiOsf-eX5TWsF0D-N6Q5SLadZqRZ9IaiI1atmEDk0oc80SMa7gdI9FpofI8_4BylsRafgCnjdQkux722_BmqleQue0-Vn-Cv6NqjJU5MjMjJ0vVGOCiI9M2kMvZGrJ1a1zj6gwkCVJfaPHnLhSLSlny_GceFJjrUL7xk7k4NuP0WEUF8QEIifqIyPE9H9fw8Xw6PzgOGouXIhUmmeLKMkzqZUsY5sm1qR5PFAxplNGc46wwjJZOMKlRsxgSlZKKi0Oy7nKdcw0U5K-gfVqWpltIKktuKEqo4Nc4RKbwhVZ8hLHyCzTqe7CZ1xyce1baog6FaGZCIYSzlDCG6oLNNhF6KZxubs_488TUlErtdosLJhchHXGz6jAyPKEHG_lGtDiwcgKkh-DZwnc0-5HjazMdDkXiQOJrEB40YW33tPadwg-i_Pe8cF2gOsXfvdJdfWr7hvuk_303epL_wE63w-H4uvo7Mt72PSbx1WfdmB9MVuaXcRjC7VX777_nAUzEQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Indications+regarding+the+management+of+interventional+clinical+trials+with+drugs+during+the+current+COVID-19+emergency+in+Italy&rft.jtitle=ESMO+open&rft.au=Pinto%2C+Carmine&rft.au=Cagnazzo%2C+Celeste&rft.date=2020-01-01&rft.pub=Elsevier+Ltd&rft.issn=2059-7029&rft.eissn=2059-7029&rft.volume=5&rft.issue=2&rft_id=info:doi/10.1136%2Fesmoopen-2020-000782&rft.externalDocID=S2059702920300788
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2059-7029&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2059-7029&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2059-7029&client=summon